ANONYMOUS: "PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin )(OND003IND) - Tabular View - ClinicalTrials.gov", 21 June 2011 (2011-06-21), Internet, pages 1 - 10, XP055486313, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/show/record/NCT01377662> [retrieved on 20180620] (B1)

BHATIA, K. S. ET AL.: "Reversal of Long-term Methamphetamine Sensitization by Combination of Pergolide with Ondansetron or Ketanserin, but not Mirtazapine.", BEHAVIOURAL BRAIN RESEARCH, vol. 223, 2011, pages 227 - 232, XP028228514 (B1)

GRADY, T. A. ET AL.: "Biological and Behavioral Responses to D-amphetamine, Alone and in Combination with the Serotonin 3 Receptor Antagonist Ondansetron", HEALTHY VOLUNTEERS. PSYCHIATRY RESEARCH, vol. 64, 1996, pages 1 - 10, XP055321105 (B1)

US-A1- 2013 116 215 (B1)

SZABO STEVEN T ET AL: "284: Translational Development of Novel Pharmacotherapeutic Strategies for Psychostimulant Dependence", BIOLOGICAL PSYCHIATRY; 65TH ANNUAL CONVENTION OF THE SOCIETY-OF-BIOLOGICAL-PSYCHIATRY, ELSEVIER SCIENCE, NEW YORK, NY; US; NEW ORLEANS, LA, USA, vol. 67, no. 9, Suppl. S, 1 May 2010 (2010-05-01), pages 88S, XP009506282, ISSN: 0006-3223, [retrieved on 20100408], DOI: 10.1016/J.BIOPSYCH.2010.03.007 (B1)

TONG H LEE ET AL: "Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: A novel treatment strategy", DRUG AND ALCOHOL DEPENDENCE, ELSEVIER SCIENTIFIC PUBLISHERS, IR, vol. 124, no. 1, 27 January 2012 (2012-01-27), pages 11 - 18, XP028520041, ISSN: 0376-8716, [retrieved on 20120202], DOI: 10.1016/J.DRUGALCDEP.2012.01.021 (B1)

US-A- 6 113 879 (B1)

LEE, T. H. ET AL.: "Pharmacologically-mediated Reactivation and Reconsolidation Blockade of the Psychostimulant-abuse Circuit: A Novel Treatment Strategy.", DRUG & ALCOHOL DEPENDENCE, vol. 124, 2012, pages 11 - 18, XP028520041 (B1)